Berenberg Downgrades PhenomeX to Hold, Lowers Price Target to $1
Portfolio Pulse from richadhand@benzinga.com
Berenberg analyst Gaurav Goparaju has downgraded PhenomeX (NASDAQ:CELL) from Buy to Hold and lowered the price target from $8 to $1.
August 22, 2023 | 9:19 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
PhenomeX has been downgraded from Buy to Hold by Berenberg, with a significant reduction in price target from $8 to $1.
The downgrade from Buy to Hold indicates a less optimistic outlook for the company's stock. The significant reduction in price target from $8 to $1 suggests that the analyst believes the stock is overvalued at its current price, which could lead to a decrease in the stock's price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100